Sort   by:  
 Page size 
UnknownPredicting MCI outcome with clinically available MRI and CSF biomarkers.
Not available
S-EPMC3198979 | biostudies-literature
UnknownDo small effects matter more in vulnerable populations? an investigation using Environmental influences on Child Health Outcomes (ECHO) cohorts.
Not available
S-EPMC11438038 | biostudies-literature
UnknownAmyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
Not available
S-EPMC4831042 | biostudies-literature
UnknownEstimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine.
Not available
S-EPMC3833961 | biostudies-literature
UnknownAmyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
Not available
S-EPMC4553028 | biostudies-literature
UnknownTHE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview.
Not available
S-EPMC5650665 | biostudies-literature
UnknownPredicting missing biomarker data in a longitudinal study of Alzheimer disease.
Not available
S-EPMC3345787 | biostudies-literature
UnknownTherapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594 | biostudies-literature
UnknownThe Concise Guide to PHARMACOLOGY 2015/16: Overview.
Not available
S-EPMC4718217 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
Sort   by:  
 Page size